Gene · 2237
Papers3,948
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,948
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proteomics analysis reveals FEN1 as a promising therapeutic target against small cell neuroendocrine carcinoma of the cervix. | Sci Rep | 2025 | 40739179 | PubTator, text mining | PubMed |
| A dual branch feature extraction network for heart sound signal analysis. | Sci Rep | 2025 | 40731147 | PubTator, text mining | PubMed |
| Autocrine interferon poisoning mediates ADAR1-dependent synthetic lethality in BRCA1/2-mutant cancers. | Nat Commun | 2025 | 40730818 | PubTator, text mining | PubMed |
| Differentiation of COVID-19 from other types of viral pneumonia and severity scoring on baseline chest radiographs: Comparison of deep learning with multi-reader evaluation. | PLoS One | 2025 | 40729327 | PubTator, text mining | PubMed |
| Participants in Transcription-Replication Conflict and Their Role in Formation and Resolution of R-Loops. | Int J Mol Sci | 2025 | 40725198 | PubTator, text mining | PubMed |
| Using the safety scissors: DNA resection regulation at DNA double-strand breaks and telomeres. | DNA Repair (Amst) | 2025 | 40716322 | PubTator, text mining | PubMed |
| Optimizing Exciton and Charge-Carrier Behavior in Thick-Film Organic Photovoltaics: A Comprehensive Review. | Nanomicro Lett | 2025 | 40696230 | PubTator, text mining | PubMed |
| FEN1 is critical for rapid single-strand break repair in G1 phase. | Nucleic Acids Res | 2025 | 40694846 | PubTator, text mining | PubMed |
| The flap endonuclease-1 promotes cellular tolerance to a chain-terminating nucleoside analog, alovudine, by counteracting the toxic effect of 53BP1. | Nucleic Acids Res | 2025 | 40685548 | PubTator, text mining | PubMed |
| Integration of AND logic circuit with CRISPR/Cas12a system for sensitive detection of biomarkers and accurate discrimination of breast cancer cells. | Biosens Bioelectron | 2025 | 40674851 | PubTator, text mining | PubMed |
| Fluorescence-Based Detection of FEN1 Nuclease Activity and Screening of Small-Molecule Inhibitors. | J Vis Exp | 2025 | 40658665 | PubTator, text mining | PubMed |
| A weighted difference loss approach for enhancing multi-label classification. | Sci Rep | 2025 | 40646048 | PubTator, text mining | PubMed |
| Correlation of senescence-related gene FEN1 on neuroblastoma progression and cisplatin chemotherapy sensitivity. | Oncol Res | 2025 | 40612863 | PubTator, text mining | PubMed |
| Exploring the pathogenesis of extranodal natural killer/T cell lymphoma complicated With EBV via microarray data analysis. | Leuk Res | 2025 | 40591982 | PubTator, text mining | PubMed |
| Correlations between genetically predicted iron-supplement drug targets and inflammatory bowel disease: A Mendelian randomization study. | Medicine (Baltimore) | 2025 | 40527798 | PubTator, text mining | PubMed |
| LNCAROD was stabilized through N6-methyladenosine methylation and exerted its anticancer effects in lung squamous cell carcinoma by inhibiting SIRT1 activity via CCAR2. | Transl Lung Cancer Res | 2025 | 40386722 | PubTator, text mining | PubMed |
| Biological activity of Arabidopsis flap endonuclease 1 (FEN1) is modulated by nuclear factors that inhibit its aggregation. | BMC Plant Biol | 2025 | 40380113 | PubTator, text mining | PubMed |
| Flap cleavage-directed promoter reconstitution and transcription reactivation for label-free and sensitive detection of flap endonuclease 1 activity. | Talanta | 2025 | 40367855 | PubTator, text mining | PubMed |
| CCCNet: Criss-cross attention enhanced cross layer refinement network for lane detection in complex scenarios. | PLoS One | 2025 | 40359328 | PubTator, text mining | PubMed |
| Versatile and programmable dual-mode logic gold nanoflares for intracellular correlated DNA repair enzymes imaging. | Biosens Bioelectron | 2025 | 40288308 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2237/papers?page=7